uniQure (QURE) Work In Process (2022 - 2024)
uniQure (QURE) recorded quarterly Work In Process of $1.3 million in Q1 2024, down 67.36% quarter-over-quarter from $4.1 million in Q4 2023.
uniQure (QURE) Work In Process (2022 - 2024) Analysis & Trends
uniQure's Work In Process history runs 3 years deep, the most recent figure standing at $1.3 million for Q1 2024.
- In Q1 2024, Work In Process changed N/A year-over-year to $1.3 million; the TTM figure through Mar 2024 stood at $1.3 million (changed N/A YoY), while the FY2023 annual figure was $4.1 million, up 119.26% from the prior year.
- Work In Process was $1.3 million for Q1 2024 at uniQure, down from $4.1 million in the prior quarter.
- In the past five years, Work In Process ranged from a high of $6.6 million in Q3 2023 to a low of $1.3 million in Q1 2024.
- Historically, Work In Process has averaged $3.4 million across 3 years, with a median of $3.1 million in 2022.
- Biggest YoY gain for Work In Process was 202.89% in 2023; the steepest drop was 119.26% in 2023.
- A 3-year view of Work In Process shows it stood at $1.9 million in 2022, then jumped by 119.26% to $4.1 million in 2023, then sank by 67.36% to $1.3 million in 2024.
- The last three Work In Process figures came in at $1.3 million (Q1 2024), $4.1 million (Q4 2023), and $6.6 million (Q3 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | uniQure | 2.88 Bn | 2.88 Bn | 3.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 1.34 Mn |
| Dec 31, 2023 | 4.11 Mn |
| Sep 30, 2023 | 6.60 Mn |
| Jun 30, 2023 | 4.06 Mn |
| Dec 31, 2022 | 1.87 Mn |
| Sep 30, 2022 | 2.18 Mn |